Skip to main content

CBRN Medical Countermeasures Workshop 2009

BARDA: CBRN Medical Countermeasures Workshop 2009
Videocast of Plenary Sessions
Day One: June 25,2009 Day Two: June 26,2009

 


Opening Remarks and Overview of Strategic Plan and CBRN Division
8:30 - 9:30AM

View Webcast and Slides

 

8:30 - 8:40 am Welcome and Opening Remarks - Dr. Carol Linden

HHS, Principal Deputy Director of the Biomedical Advanced Research and Development Authority, BARDA

8:40 - 8:50 am Overview of BARDA and the CBRN Division - Dr. Gary Disbrow

Deputy Director, CBRN Division of Countermeasures, BARDA

8:50 - 9:00 am Overview of CBRN Strategic Plan - Dr. Gerald Kovacs

Director, CBRN Division Countermeasures, BARDA

 


Programmatic Presentations by BARDA Staff
9:00 - 10:15 AM

View Webcast and Slides

9:00 - 10:00 am Programmatic Presentations by BARDA Staff

  • Anthrax Vaccines - Dr. Narayan Iyer, Chief Anthrax Vaccines
  • Antitoxins - Dr. Stephen Morris, Chief, Anthrax Therapeutics
  • Chem/Rad/Nuc - Dr. Ronald Manning, Chief Chemical Radiological Nuclear Countermeasures
  • Smallpox - Dr. Dawn Myscofski, Chief Smallpox Vaccines
  • SSTD - Dr. Jerome Donlon, Director Strategic Science and Technology Division

10:00 - 10:15 am Panel Q&A with Directors and Branch Chiefs

 


Online Resources and Requirements Generation
10:30-11:30 AM

View Webcast and Slides

 

10:30 - 10:40 am Overview of Medical Countermeasures Website and Navigation -

Ms. Elizabeth Jarrett, Program Analyst, BARDA

10:40 - 11:15 am Requirements Generation

  • Department of Homeland Security - Dr. Diane Berry - Chief Scientist, Office of Health Affairs, DHS
  • Policy Planning and Requirements for BARDA - Dr. Joanna Prasher - Rad/Nuc Policy Planning and Requirements, BARDA
  • BARDA Modeling Group - Ms. Mary Beth Hill-Harmon - Program Analyst, Modeling, BARDA

 

11:15 - 11:30 am Panel Q & A with Presenters

 


Integrated National Biodefense Portfolio and Funding Mechanisms
10:30-11:30 AM

View Webcast and Slides

 

11:30 - 12:30 pm Overview of Integrated National Biodefense Portfolio - Dr. Carol Linden - Principal Deputy Director, BARDA

Funding Mechanisms and Roles in Development of Medical Countermeasures

  • Dr. Albert Churilla, Chief, Medical Science and Technology Division,
    Chemical / Biological Technologies Directorate, Joint Science & Technology Office Defense Threat Reduction Agency
  • Dr. Helen Schiltz, Acting Chief, Drug Development Section,
    Office of Biodefense Research Affairs, Division of Microbiology and Infectious Diseases, NIAID, NIH

12:30 -12:45 pm Q & A

 

 


The Regulatory Pathway and Closing Remarks
2:00 - 3:30 PM

View Webcast and Slides

 

2:00 - 3:00 pm Regulatory Issues, Critical Path and Lessons Learned

  • Animal Rule - Dr. Rosemary Roberts
    Director, Office of Counterterrorism and Emergency Coordination, Center for Drug Evaluation and Research, FDA
  • EUA and Contingency Use - Dr. Debra Yeskey
    Director, Regulatory and Quality Affairs Division, BARDA
  • SNS and Their Role in Stockpiling & Deployment - Dr. Susan Gorman
    Division of Strategic National Stockpile, CDC
  • Critical Path and Lessons Learned -
    Dr. Thomas Dreier - Subject Matter Expert, BARDA/CBRN
    Dr. Michael Merchlinsky - Subject Matter Expert, BARDA/CBRN
    Mr. David Aglow - Subject Matter Expert, BARDA/CBRN

3:00 -3:15 pm Panel Q & A

 

3:15 -3:30 pm Closing Remarks and Wrap Up - Dr. Gerald Kovacs
Director, CBRN Division Countermeasures